Siakallis Loizos C, Uddin Jimmy M, Miszkiel Katherine A
Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Moorfields Eye Hospital, London, United Kingdom.
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S41-S51. doi: 10.1097/IOP.0000000000001139.
Thyroid eye disease (TED), is a term referring to the extrathyroidal manifestation of Grave's disease, a disorder which is currently the most common cause of hyperthyroidism and is characterised by underlying autoimmunity.The pathogenic course of the disease can be broadly classified into two stages, an early inflammatory and a late fibrotic stage. These stages are reflected in clinical severity and activity classifications, such as Clinical Activity Score and Class 0: No signs or symptoms, 1: Only signs, no symptoms (e. g. lid retraction), 2: Soft tissue involvement, 3: Proptosis, 4: Extraocular muscle involvement, 5: Corneal involvement, 6: Sight loss (NOSPECS). Classifications based on the latter, have important implications in treatment decisions since patients in the early active stage of the disease are more likely to respond to anti-inflammatory and immunosuppressive therapies, whereas patients in the late fibrotic stage require different therapeutic approaches, including rehabilitative surgery.
We reviewed cases of TED investigated with CT and Magnetic Resonance Imaging (MRI) in our department. We assessed the findings of imaging studies and their role in the clinical investigation of patients with TED as well as in the differential diagnosis from other disorders.
Imaging has a significant role in the investigation of TED, however a consensus on the use of different imaging modalities in the course of disease has yet to be reached. Nevertheless, imaging and specifically CT and MRI can have a vital role in the initial diagnosis of clinically atypical presentation of TED, in surgical planning, as well as in the differential diagnosis from other orbital disorders.
In this review, we attempt to present current trends in imaging investigation of TED. Rather than focusing on the findings of each imaging modality separately, we present the two main imaging modalities focusing on CT and MRI, in the context of pathogenic stages of the disease.
甲状腺眼病(TED)是指格雷夫斯病的甲状腺外表现,格雷夫斯病是目前甲状腺功能亢进最常见的病因,其特征为潜在的自身免疫性。该疾病的致病过程大致可分为两个阶段,即早期炎症阶段和晚期纤维化阶段。这些阶段反映在临床严重程度和活动度分类中,如临床活动评分以及0级:无体征或症状;1级:仅有体征,无症状(如眼睑退缩);2级:软组织受累;3级:眼球突出;4级:眼外肌受累;5级:角膜受累;6级:视力丧失(NOSPECS)。基于后者的分类在治疗决策中具有重要意义,因为处于疾病早期活动阶段的患者更可能对抗炎和免疫抑制治疗有反应,而处于晚期纤维化阶段的患者需要不同的治疗方法,包括修复性手术。
我们回顾了在我们科室接受CT和磁共振成像(MRI)检查的甲状腺眼病病例。我们评估了影像学检查的结果及其在甲状腺眼病患者临床检查以及与其他疾病鉴别诊断中的作用。
影像学在甲状腺眼病的检查中具有重要作用,然而对于在疾病过程中使用不同影像学检查方法尚未达成共识。尽管如此,影像学尤其是CT和MRI在甲状腺眼病临床非典型表现的初始诊断、手术规划以及与其他眼眶疾病的鉴别诊断中可发挥关键作用。
在本综述中,我们试图呈现甲状腺眼病影像学检查的当前趋势。我们并非分别聚焦于每种影像学检查方法的结果,而是在疾病致病阶段的背景下,呈现以CT和MRI为主的两种主要影像学检查方法。